Home › Studies › PRJNA1074135
PRJNA1074135 SRP489634

Ciprofloxacin effects on gut/oral microbiome in UTI, case-control

Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses

295 stool and oropharyngeal samples from UTI patients treated with ciprofloxacin (short ≤7 days vs long >7 days courses) and untreated controls, collected in Geneva (Switzerland), Lodz (Poland), and Antwerp (Belgium); case-control design. machine-written summary

295 samples · 295 runs · CH, PL, BE · Age unknown · 2024 · 0.67 Gbp / sample

One study deposited as 2 BioProjects (590 catalog samples together): PRJEB72433 · PRJNA1074135 · show together

Sources
✓Sequence archive 2,532○Abstract / description–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive2,532 sample values (antibiotic exposure, collection date, country, intervention, latitude, location locality, location region, longitude)
○ Abstract / descriptionread; no usable statement
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet · share metadata
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

EAntibiotic given as the study intervention (incl. eradication therapy: 36 people · 211 samplesantibiotic 36 people · 211 samplesControl / pre-intervention baseline (sample level only): 14 people · 84 samplesno intervention 14 people · 84 samples
exposed vs. not exposed (observational)

design observational_with_procedure

Samples at a glance
3 sampling locations · 3 countries
Age
unknown295
Country
CH180
PL88
BE27
Body site
primary150
excluded145
Collected 2011–2013
2011: 155 samples2012: 110 samples2013: 30 samples20112013
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 13 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 55 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 156 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 71 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.67 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

50 of 50 people sampled more than once (150 samples; median 3, up to 3 per person) · follow-up median 36 d (max 2 mo) · median interval between samples 17 d (time from collection dates).

001001: day 0001: day 7001: day 45002002: day 0002: day 7002: day 35003003: day 0003: day 6003: day 34004004: day 0004: day 8004: day 36005005: day 0005: day 4005: day 39006006: day 0006: day 6006: day 39007007: day 0007: day 7007: day 35008008: day 0008: day 7008: day 34009009: day 0009: day 7009: day 35010010: day 0010: day 8010: day 35011011: day 0011: day 10011: day 39012012: day 0012: day 7012: day 37013013: day 0013: day 7013: day 36014014: day 0014: day 7014: day 35015015: day 0015: day 7015: day 32016016: day 0016: day 6016: day 33017017: day 0017: day 7017: day 35018018: day 0018: day 16018: day 43019019: day 0019: day 7019: day 35020020: day 0020: day 8020: day 35021021: day 0021: day 8021: day 29022022: day 0022: day 7022: day 35023023: day 0023: day 6023: day 42024024: day 0024: day 8024: day 42025025: day 0025: day 5025: day 34026026: day 0026: day 7026: day 34027027: day 0027: day 4027: day 32028028: day 0028: day 7028: day 35029029: day 0029: day 7029: day 35030030: day 0030: day 12030: day 46031031: day 0031: day 7031: day 35032032: day 0032: day 7032: day 35033033: day 0033: day 8033: day 36034034: day 0034: day 10034: day 38035035: day 0035: day 12035: day 39036036: day 0036: day 10036: day 410 d12 d23 d34 d46 d

Each row is one person (36 shown of 50); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Blautia_A 10.0%Roseburia 5.9%Bifidobacterium 5.7%Bacteroides 5.3%Ruminococcoides 4.5%Faecalibacterium 3.8%Anaerostipes 3.2%Phocaeicola 2.7%Anaerobutyricum 2.6%Collinsella 2.5%Dorea_A 2.4%Mediterraneibacter 2.2%not assigned to a genus 12.1%other genera 37.1%

Genera, mean relative abundance over 138 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country295 100%295
health_condition0 0%
subject_id295 100%295
collection_date295 100%295
detailed_location295 100%
intervention295 100%295
latitude295 100%295
longitude295 100%295
timepoint_label295 100%295
location_locality268 91%268
location_region115 39%115
antibiotic_exposure84 28%84
Papers (1)
  • Long-term effects of ciprofloxacin treatment on the gastrointestinal and oropharyngeal microbiome are more pronounced after longer antibiotic courses. 2024 PMID 38936492 own_data
Details
Archive description

This study performed shotgun metagenomic sequencing on stool and oropharyngeal samples obtained from patients presenting with uncomplicated UTI to primary care and receiving ciprofloxacin treatment. Duration of treatment was different across the patients and categorized as short (less or equal to 7 days) or long ( more than 7 days). Control subjects not undergoing antibiotic treatment were also included.

How this project entered the registry

Classified as human gut / stool / oral cavity / nasal / nasopharyngeal shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.75. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site run.scientific_name · “gut metagenome”
  • body site run.scientific_name · “human oral metagenome”
  • body site sample.attr.isolation_source · “Oropharynx (n=145/295)”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN39918592antibiotic_exposurenoR10.70sample.name_rule:aliasSATURN_001_untreated_OP1
SAMN39918592collection_date2011-01-17R10.90biosample.attribute:collection_date2011-01-17
SAMN39918592countryCHR10.90sample.attr.geo_loc_nameSwitzerland: Geneva
SAMN39918592interventionno_interventionR10.70sample.name_rule:aliasalias: SATURN_001_untreated_OP1
SAMN39918592latitude46.2000R10.90biosample.attribute:lat_lon46.20 N 6.10 E
SAMN39918592location_localityGenevaR10.85biosample.attribute:geo_loc_nameSwitzerland: Geneva
SAMN39918658location_regionAntwerpR10.85biosample.attribute:geo_loc_nameBelgium: Antwerp
SAMN39918670location_regionLodz VoivodeshipR10.60biosample.attribute:lat_lon51.75 N 19.46 E
SAMN39918592longitude6.1000R10.90biosample.attribute:lat_lon46.20 N 6.10 E
SAMN39918592subject_id001R10.70sample.name_rule:aliasalias: SATURN_001_untreated_OP1
SAMN39918592timepoint_label1R10.70sample.name_rule:aliasSATURN_001_untreated_OP1
Sequencing

295 runs over 295 samples · mean 0.67 Gbp per run (median 0.67 Gbp, total 198.40 Gbp; 295 runs with a base count) · layout PAIRED 295 · platform ILLUMINA 295 · models Illumina MiSeq (295) · 87% of runs with a Sandpiper profile · first public 2024-06-21

Authors (0)

No author record.

Help complete this project

2 of the 4 core fields are below 50% coverage: age_category, health_condition. Share metadata

Downloads

PRJNA1074135.csv.gz (9.0 KB) · parquet (81.9 KB) — all 295 samples, every field with route and confidence · PRJNA1074135_determinations.csv.gz (21.6 KB) — 2,532 evidence rows

Samples (295 · every field this project has values for · hover a cell for its source)
Loading the sample table…